Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas.
Ohmachi Y, Yamamoto M, Inaba Y, Makino S, Urai S, Matsumoto R, Bando H, Kanie K, Tsujimoto Y, Motomura Y, Sasaki Y, Oi-Yo Y, Yamamoto N, Suzuki M, Takahashi M, Iguchi G, Kanzawa M, Furukawa J, Shigemura K, Mizobuchi S, Ogawa W, Fukuoka H. Ohmachi Y, et al. Among authors: yamamoto n, yamamoto m. Endocrine. 2024 May;84(2):694-703. doi: 10.1007/s12020-023-03681-4. Epub 2024 Jan 11. Endocrine. 2024. PMID: 38206436
Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitis.
Bando H, Yamamoto M, Urai S, Motomura Y, Sasaki Y, Ohmachi Y, Kobatake M, Tsujimoto Y, Oi-Yo Y, Suzuki M, Yamamoto N, Takahashi M, Fukuoka H, Iguchi G, Ogawa W. Bando H, et al. Among authors: yamamoto n, yamamoto m. J Immunother Cancer. 2024 Feb 28;12(2):e008634. doi: 10.1136/jitc-2023-008634. J Immunother Cancer. 2024. PMID: 38418395 Free PMC article.
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan.
Oi-Yo Y, Yamamoto M, Urai S, Bando H, Ohmachi Y, Motomura Y, Kobatake M, Tsujimoto Y, Sasaki Y, Suzuki M, Yamamoto N, Takahashi M, Iguchi G, Ogawa W, Takahashi Y, Fukuoka H. Oi-Yo Y, et al. Among authors: yamamoto n, yamamoto m. Pituitary. 2024 Oct;27(5):605-613. doi: 10.1007/s11102-024-01459-z. Epub 2024 Sep 19. Pituitary. 2024. PMID: 39298061
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE–IVUS Investigators. Tsujita K, et al. Among authors: yamamoto n. J Am Coll Cardiol. 2015 Aug 4;66(5):495-507. doi: 10.1016/j.jacc.2015.05.065. J Am Coll Cardiol. 2015. PMID: 26227186 Free article. Clinical Trial.
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
Nakashima K, Harashima S, Kaneko R, Tanaka R, Abe M, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Satomi E, Takeda M, Nakajima TE, Nakamura N, Nishimura J, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K, Sasaki H. Nakashima K, et al. Among authors: yamamoto n. Int J Clin Oncol. 2024 Nov 12. doi: 10.1007/s10147-024-02652-7. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39531096
Floating Inferior Glenohumeral Ligament: A Case Report.
Ishidu N, Yamamoto N, Sato H, Aizawa T, Itoi E. Ishidu N, et al. Among authors: yamamoto n. Cureus. 2024 Oct 10;16(10):e71189. doi: 10.7759/cureus.71189. eCollection 2024 Oct. Cureus. 2024. PMID: 39525175 Free PMC article.
6,367 results